動物用静注ソリューションの世界市場レポート 2025年

動物用静注ソリューションの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で21億9,000万米ドルに成長すると予想されます。予測期間の成長は、ペット保険導入の増加、動物ヘルスケア支出の増加、動物ヘルスケアに対する意識の高まり、動物疾病の発生率の上昇、ペット保険加入率の上昇に起因しています。予測期間の主な動向には、技術の進歩、多様な製品処方、遠隔医療統合、高度な動物用静脈内投与システム、スマート動物用静脈内投与システムなどがあります。

さまざまな動物疾病の蔓延は、動物用静注ソリューション市場の拡大を促進すると予想されます。動物の病気は、動物の健康や機能に悪影響を及ぼす病態であり、炭疽、レプトスピラ症、狂犬病、犬ジステンパー、心臓病などが一般的な例です。これらの病気の増加は、集約的な農法、野生動物の侵入、抗生物質耐性などの要因によるものです。動物用静注製剤は、胃腸炎や重度の感染症などの病気による脱水症状に苦しむ動物に水分を補給することで、適切な水分補給を確保し、健康全般をサポートするという重要な役割を担っています。例えば、米国獣医師会が2024年7月に報告したところによると、2022年に家畜で確認された狂犬病の症例数は345件で、2021年の311件から10.9%増加しました。このように、動物疾病の増加が動物用静注ソリューション市場の成長を後押ししています。

動物用医薬品への支出の増加も、動物用静注ソリューション市場の成長を促進すると予想されます。動物用医薬品には、動物の健康維持・増進を目的とした医薬品、サプリメント、治療が含まれます。これらの製品への支出が増加している背景には、ペットの飼育数の増加、動物の健康に対する意識の高まり、獣医学的ケアの進歩、病気の予防と治療の改善に対するニーズなどの要因があります。動物用静注ソリューションは、緊急の医療ニーズに対応し、獣医療を強化することで、この動向に貢献しています。例えば、エストニア共和国医薬品庁は2024年3月に、動物用医薬品市場が2022年の1,921万米ドル（1,740万ユーロ）から2023年には6.9%成長し、2,054万米ドル（1,860万ユーロ）に達したと報告しています。このような動物用医薬品への支出の増加が、動物用静注ソリューション市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動物用静注ソリューション市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の動物用静注ソリューション市場：成長率分析
• 世界の動物用静注ソリューション市場の実績：規模と成長、2019～2024年
• 世界の動物用静注ソリューション市場の予測：規模と成長、2024～2029年、2034年
• 世界の動物用静注ソリューション総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物用静注ソリューション市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 等張晶質液
• ブドウ糖液
• 合成コロイド
• 天然コロイド
• 経腸栄養
• 世界の動物用静注ソリューション市場：動物の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• コンパニオンアニマル
• 生産動物
• 世界の動物用静注ソリューション市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 動物病院・クリニック
• 研究機関
• その他
• 世界の動物用静注ソリューション市場：等張晶質液のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生理食塩水（0.9% NaCl）
• 乳酸リンゲル液
• ブドウ糖水溶液（D5W）
• リンゲル液
• バランス電解質溶液
• 世界の動物用静注ソリューション市場：ブドウ糖液のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ブドウ糖5%水溶液（D5W）
• ブドウ糖10%水溶液（D10W）
• ブドウ糖20%水溶液（D20W）
• ブドウ糖50%水溶液（D50W）
• 世界の動物用静注ソリューション市場：合成コロイドのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒドロキシエチルデンプン（HES）
• デキストラン
• ゼラチン
• 世界の動物用静注ソリューション市場：天然コロイドのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アルブミン
• 新鮮凍結血漿（FFP）
• 血液製品
• 世界の動物用静注ソリューション市場：経腸栄養のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 完全静脈栄養（TPN）ソリューション
• 部分的静脈栄養ソリューション
• 脂質乳剤
• アミノ酸ソリューション

第7章 地域別・国別分析

• 世界の動物用静注ソリューション市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の動物用静注ソリューション市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用静注ソリューション市場：競合情勢
• 動物用静注ソリューション市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• B. Braun Melsungen AG
• Virbac SA
• Dechra Pharmaceuticals PLC
• Vetoquinol SA
• Norbrook Laboratories Limited
• Ceva Sante Animale
• Revival Animal Health Inc.
• Aromor Animal Health
• Jorgensen Laboratories LLC
• Pharmacosmos AS
• Sykes Veterinary International Pty Ltd.
• Rusoma Laboratories Private Limited
• Patterson Companies Inc.
• NexGen Veterinary
• Soxa Formulations & Research Pvt.Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物用静注ソリューション市場2029：新たな機会を提供する国
• 動物用静注ソリューション市場2029：新たな機会を提供するセグメント
• 動物用静注ソリューション市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary intravenous (IV) solutions are sterile fluids administered directly into an animal's bloodstream through a vein, usually via an IV catheter. These solutions are used in veterinary care to treat dehydration and electrolyte imbalances, deliver medications, or provide essential nutrients. They are crucial for maintaining or restoring fluid and electrolyte balance in animals, particularly during illness, surgery, or trauma.

The main types of veterinary intravenous (IV) solutions include isotonic crystalloids, dextrose solutions, synthetic colloids, natural colloids, and parenteral nutrition. Isotonic crystalloids are IV fluids with a solute concentration equal to that of the blood, helping to maintain fluid balance. These solutions are applicable to various animal types, including companion animals and production animals. They are used by different end-users such as veterinary hospitals and clinics, research institutes, and other related entities.

The veterinary intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides veterinary intravenous solutions market statistics, including veterinary intravenous solutions industry global market size, regional shares, competitors with a veterinary intravenous solutions market share, detailed veterinary intravenous solutions market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary intravenous solutions industry. This veterinary intravenous solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary intravenous (IV) solutions market size has grown strongly in recent years. It will grow from $1.5 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing number of veterinary clinics, rise in incidence of dehydration, growth in livestock farming, rise in the number of companion animals, and growth in veterinary diagnostics.

The veterinary intravenous (IV) solutions market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising adoption of pet insurance, increasing animal healthcare expenditure, growing awareness of animal healthcare, rising incidence of animal diseases, and increasing pet insurance coverage. Major trends in the forecast period include technological advancements, diverse product formulations, telemedicine integration, advanced veterinary intravenous (IV) delivery systems, and smart veterinary intravenous (IV) systems.

The growing prevalence of various animal diseases is anticipated to drive the expansion of the veterinary intravenous (IV) solutions market. Animal diseases are conditions that negatively affect the health and function of animals, with common examples including anthrax, leptospirosis, rabies, canine distemper, and heartworm disease. The rise in these diseases is attributed to factors such as intensive farming practices, wildlife encroachment, and antibiotic resistance. Veterinary IV solutions play a crucial role in rehydrating animals suffering from dehydration caused by illnesses such as gastroenteritis or severe infections, thereby ensuring proper hydration and supporting overall health. For instance, the American Veterinary Medical Association reported in July 2024 that there were 345 confirmed cases of rabies in domestic animals in 2022, a 10.9% increase from the 311 cases in 2021. Thus, the increase in animal diseases is boosting the growth of the veterinary IV solutions market.

Rising expenditure on animal health products is also expected to propel the growth of the veterinary intravenous (IV) solutions market. Animal health products include medications, supplements, and treatments aimed at maintaining or improving animal health. The rise in spending on these products is driven by factors such as increased pet ownership, greater awareness of animal health, advancements in veterinary care, and the need for improved disease prevention and treatment. Veterinary IV solutions contribute to this trend by addressing urgent medical needs and enhancing veterinary care. For example, the Republic of Estonia Agency of Medicines reported in March 2024 that the veterinary medicinal products market grew by 6.9% in 2023, reaching $20.54 million (18.6 million euros), up from $19.21 million (17.40 million euros) in 2022. This increase in spending on animal health products is driving the growth of the veterinary IV solutions market.

Leading companies in the veterinary IV solutions market are focusing on developing advanced products, such as fluoroquinolone antibiotics, to enhance efficacy and safety. Fluoroquinolones are a potent class of antibiotics used in both human and veterinary medicine to treat a variety of bacterial infections, with careful management to prevent resistance and side effects. For example, in April 2024, Elanco, a US-based pharmaceutical company, introduced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA). This 3rd generation fluoroquinolone is approved for treating swine respiratory disease (SRD) caused by several pathogens, including Bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. The drug's label advises that it should be used only after other non-fluoroquinolone treatment options have been considered.

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Sante Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary intravenous (IV) solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary intravenous (IV) solutions market consists of sales of hypertonic solutions, isotonic solutions, and hypertonic solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Intravenous (IV) Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary intravenous (iv) solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary intravenous (iv) solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary intravenous (iv) solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Isotonic Crystalloids; Dextrose Solutions; Synthetic Colloids; Natural Colloids; Parenteral Nutrition
• 2) By Animal Type: Companion Animals; Production Animals
• 3) By End-User: Veterinary Hospitals And Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) Isotonic Crystalloids: Normal Saline (0.9% NaCl); Lactated Ringer's Solution; Dextrose in Water (D5W); Ringer's Solution; Balanced Electrolyte Solutions
• 2) Dextrose Solutions: Dextrose 5% in Water (D5W); Dextrose 10% in Water (D10W); Dextrose 20% in Water (D20W); Dextrose 50% in Water (D50W)
• 3) Synthetic Colloids: Hydroxyethyl Starch (HES); Dextran; Gelatins
• 4) Natural Colloids: Albumin; Fresh Frozen Plasma (FFP); Blood Products
• 5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions; Partial Parenteral Nutrition Solutions; Lipid Emulsions; Amino Acid Solutions
• Companies Mentioned: Merck & Co. Inc.; Baxter International Inc.; Zoetis Inc.; Fresenius Kabi AG; Elanco Animal Health Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Intravenous (IV) Solutions Market Characteristics

3. Veterinary Intravenous (IV) Solutions Market Trends And Strategies

4. Veterinary Intravenous (IV) Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Intravenous (IV) Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Intravenous (IV) Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Intravenous (IV) Solutions Market Growth Rate Analysis
• 5.4. Global Veterinary Intravenous (IV) Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Intravenous (IV) Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Intravenous (IV) Solutions Total Addressable Market (TAM)

6. Veterinary Intravenous (IV) Solutions Market Segmentation

• 6.1. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isotonic Crystalloids
• Dextrose Solutions
• Synthetic Colloids
• Natural Colloids
• Parenteral Nutrition
• 6.2. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animals
• Production Animals
• 6.3. Global Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals And Clinics
• Research Institutes
• Other End-Users
• 6.4. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Isotonic Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Normal Saline (0.9% NaCl)
• Lactated Ringer's Solution
• Dextrose in Water (D5W)
• Ringer's Solution
• Balanced Electrolyte Solutions
• 6.5. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Dextrose Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dextrose 5% in Water (D5W)
• Dextrose 10% in Water (D10W)
• Dextrose 20% in Water (D20W)
• Dextrose 50% in Water (D50W)
• 6.6. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Synthetic Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydroxyethyl Starch (HES)
• Dextran
• Gelatins
• 6.7. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Natural Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Albumin
• Fresh Frozen Plasma (FFP)
• Blood Products
• 6.8. Global Veterinary Intravenous (IV) Solutions Market, Sub-Segmentation Of Parenteral Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Parenteral Nutrition (TPN) Solutions
• Partial Parenteral Nutrition Solutions
• Lipid Emulsions
• Amino Acid Solutions

7. Veterinary Intravenous (IV) Solutions Market Regional And Country Analysis

• 7.1. Global Veterinary Intravenous (IV) Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Intravenous (IV) Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Intravenous (IV) Solutions Market

• 8.1. Asia-Pacific Veterinary Intravenous (IV) Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Intravenous (IV) Solutions Market

• 9.1. China Veterinary Intravenous (IV) Solutions Market Overview
• 9.2. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Intravenous (IV) Solutions Market

• 10.1. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Intravenous (IV) Solutions Market

• 11.1. Japan Veterinary Intravenous (IV) Solutions Market Overview
• 11.2. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Intravenous (IV) Solutions Market

• 12.1. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Intravenous (IV) Solutions Market

• 13.1. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Intravenous (IV) Solutions Market

• 14.1. South Korea Veterinary Intravenous (IV) Solutions Market Overview
• 14.2. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Intravenous (IV) Solutions Market

• 15.1. Western Europe Veterinary Intravenous (IV) Solutions Market Overview
• 15.2. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Intravenous (IV) Solutions Market

• 16.1. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Intravenous (IV) Solutions Market

• 17.1. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Intravenous (IV) Solutions Market

• 18.1. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Intravenous (IV) Solutions Market

• 19.1. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Intravenous (IV) Solutions Market

• 20.1. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Intravenous (IV) Solutions Market

• 21.1. Eastern Europe Veterinary Intravenous (IV) Solutions Market Overview
• 21.2. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Intravenous (IV) Solutions Market

• 22.1. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Intravenous (IV) Solutions Market

• 23.1. North America Veterinary Intravenous (IV) Solutions Market Overview
• 23.2. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Intravenous (IV) Solutions Market

• 24.1. USA Veterinary Intravenous (IV) Solutions Market Overview
• 24.2. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Intravenous (IV) Solutions Market

• 25.1. Canada Veterinary Intravenous (IV) Solutions Market Overview
• 25.2. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Intravenous (IV) Solutions Market

• 26.1. South America Veterinary Intravenous (IV) Solutions Market Overview
• 26.2. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Intravenous (IV) Solutions Market

• 27.1. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Intravenous (IV) Solutions Market

• 28.1. Middle East Veterinary Intravenous (IV) Solutions Market Overview
• 28.2. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Intravenous (IV) Solutions Market

• 29.1. Africa Veterinary Intravenous (IV) Solutions Market Overview
• 29.2. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Animal Type
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Intravenous (IV) Solutions Market Competitive Landscape
• 30.2. Veterinary Intravenous (IV) Solutions Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Intravenous (IV) Solutions Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Virbac SA
• 31.3. Dechra Pharmaceuticals PLC
• 31.4. Vetoquinol SA
• 31.5. Norbrook Laboratories Limited
• 31.6. Ceva Sante Animale
• 31.7. Revival Animal Health Inc.
• 31.8. Aromor Animal Health
• 31.9. Jorgensen Laboratories LLC
• 31.10. Pharmacosmos AS
• 31.11. Sykes Veterinary International Pty Ltd.
• 31.12. Rusoma Laboratories Private Limited
• 31.13. Patterson Companies Inc.
• 31.14. NexGen Veterinary
• 31.15. Soxa Formulations & Research Pvt.Ltd

32. Global Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Intravenous (IV) Solutions Market

34. Recent Developments In The Veterinary Intravenous (IV) Solutions Market

35. Veterinary Intravenous (IV) Solutions Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Intravenous (IV) Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Intravenous (IV) Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Intravenous (IV) Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33616_Veterinary_Intravenous_IV_Solutions_GMR_2025